Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine

Clinical trial NCT00440167 · UNKNOWN

Trial details

NCT number: NCT00440167
Sponsor: PD Dr. med. Volker Heinemann
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2006-06-01
Primary completion: 2011-12-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.